Goyescas Broncovac 2
Product Images NDC 11856-0017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Goyescas Broncovac 2 (NDC 11856-0017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Goyescas Of Fla, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Goyescas Broncovac 2 Alcohol And Sugar Free 6 Oz. Carton 001)

Carton (Goyescas Broncovac 2 Alcohol And Sugar Free 6 Oz. Carton 001)
This is a drug facts label for a cough and cold medication that contains dextromethorphan, guaifenesin and phenylephrine, which function as cough suppressant, expectorant, and nasal decongestant, respectively. It helps loosen phlegm and temporarily relieves symptoms such as nasal congestion, cough, and minor irritations in the respiratory system. The medication may cause adverse effects and it is advised to consult a physician if the patient is under 6 years old, pregnant, or breastfeeding. The label provides directions for use for patients over 6 years old, in addition to a list of inactive ingredients. The medication is distributed by Goyescasusa.com, Miami, Florida.*
FDA Label Image

Label (Goyescas Broncovac 2 Alcohol And Sugar Free 6 Oz. Label 001)

Label (Goyescas Broncovac 2 Alcohol And Sugar Free 6 Oz. Label 001)
This is a drug facts description of a cold and cough expectorant that includes dextromethorphan HBr for cough suppression and phenylephrine HCI as a nasal decongestant. It also includes guaifenesin to help loosen phlegm and bronchial secretions. The product is designed to relief symptoms that occur with colds, including coughs and nasal congestion. The warning advises not to use the product if certain drugs are being taken and to contact a doctor if the cough lasts for more than seven days, comes back, or is associated with fever, headache or rash. The product is available in a Tablespoonful dose that can be taken every 6 hours by adults and children 12 years of age and over, and a Teaspoonful dose that can be taken by children under 12 years of age. The product includes several inactive ingredients and is manufactured by GOVESCIN.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.